Pietro Pioltelli
Overview
Explore the profile of Pietro Pioltelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1058
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tournilhac O, van Gelder M, Eikema D, Zinger N, Dreger P, Bornhauser M, et al.
Bone Marrow Transplant
. 2023 Mar;
58(6):621-624.
PMID: 36977926
Allogeneic transplantation (allo-HCT) is a curative treatment in CLL whose efficacy including the most severe forms had led to the 2006 EBMT recommendations. The advent after 2014 of targeted therapies...
2.
Baron F, Labopin M, Tischer J, Ciceri F, Raiola A, Blaise D, et al.
Bone Marrow Transplant
. 2022 Oct;
57(11):1747.
PMID: 36280760
No abstract available.
3.
Nagler A, Labopin M, Swoboda R, Pioltelli P, Arat M, Yakoub-Agha I, et al.
Hemasphere
. 2022 Oct;
6(11):e790.
PMID: 36258924
The results of haploidentical stem cell transplantation (haploHCT) for patients with acute lymphoblastic leukemia (ALL) transplanted in active disease remain largely unknown. We retrospectively analyzed adult patients with R/R ALL...
4.
Kharfan-Dabaja M, Labopin M, Bazarbachi A, Salmenniemi U, Mielke S, Chevallier P, et al.
Hemasphere
. 2022 Oct;
6(11):e788.
PMID: 36258923
Outcomes of allogeneic hematopoietic cell transplantation (allo-HCT) for adult acute lymphoblastic leukemia (ALL) have improved over time. Studies have shown that total body irradiation (TBI) is the preferable type of...
5.
Baron F, Labopin M, Tischer J, Ciceri F, Raiola A, Blaise D, et al.
Bone Marrow Transplant
. 2022 Aug;
57(11):1657-1663.
PMID: 35978005
HLA-haploidentical allogeneic hematopoietic stem cell transplantation (Haplo-HCT) is frequently used as treatment for patients with active acute myeloid leukemia (AML). Here, we investigated whether 9/10 HLA-mismatched unrelated donor transplantation (MMUD-HCT)...
6.
Swoboda R, Labopin M, Giebel S, Angelucci E, Arat M, Aljurf M, et al.
Bone Marrow Transplant
. 2022 Jan;
57(3):399-406.
PMID: 35031709
Optimal conditioning for adults with acute lymphoblastic leukemia (ALL) treated with haploidentical hematopoietic cell transplantation (haplo-HCT) and post-transplant cyclophosphamide has not been established so far. We retrospectively compared outcomes for...
7.
Mikulska M, Tridello G, Hoek J, Gil L, Yanez L, Labussiere-Wallet H, et al.
Bone Marrow Transplant
. 2021 May;
56(10):2555-2566.
PMID: 34023859
Limited data are available on legionellosis after hematopoietic stem cell transplant (HSCT). The aim of this study was to report the cases of legionellosis and to identify predictors of legionellosis,...
8.
Picardi A, Sacchi N, Miotti V, Lorentino F, Oldani E, Rambaldi A, et al.
Transplant Cell Ther
. 2021 May;
27(5):406.e1-406.e11.
PMID: 33965179
HLA molecules are important for immunoreactivity in allogeneic hematopoietic stem cell transplantation (HSCT). The Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione...
9.
Nagler A, Labopin M, Koc Y, Angelucci E, Tischer J, Arat M, et al.
Cancer
. 2021 Mar;
127(14):2507-2514.
PMID: 33739471
Background: The use of haploidentical hematopoietic cell transplantation (haplo-HCT) with posttransplantation cyclophosphamide prophylaxis is gaining traction in patients with acute lymphoblastic leukemia (ALL). Methods: The Acute Leukemia Working Party/European Society...
10.
Battipaglia G, Mauff K, Wendel L, Angelucci E, Mohty M, Arcese W, et al.
Bone Marrow Transplant
. 2021 Feb;
56(7):1593-1602.
PMID: 33526919
Allogeneic hematopoietic cell transplantation (allo-HCT) remains the only curative option in MF. There is no consensus on the optimal conditioning regimen. We report outcomes of 187 patients with MF transplanted...